Company Filing History:
3 out of 839 
3 out of 5,463 
Years Active: 2019-2021
Title: Daad Abi-Ghanem: Innovator in Vaccine Development
Introduction
Daad Abi-Ghanem is a notable inventor based in Tigard, OR (US). He has made significant contributions to the field of immunology, particularly in the development of vaccine vectors aimed at enhancing immune responses to enteric pathogens. With a total of 3 patents, his work is paving the way for advancements in vaccine technology.
Latest Patents
Abi-Ghanem's latest patents focus on compositions and methods for enhancing immune responses to enteric pathogens. These patents describe vaccine vectors capable of eliciting an immune response to enteric bacteria. The vaccine vectors include a polynucleotide encoding a PAL polypeptide, which may be expressed on the surface of the vaccine vector. Additionally, the vaccine vector may incorporate a second polypeptide encoding an immunostimulatory polypeptide, such as a CD154 polypeptide or an HMGB1 polypeptide.
Career Highlights
Throughout his career, Daad Abi-Ghanem has worked with esteemed institutions, including the University of Arkansas and Texas A&M University System. His research has significantly contributed to the understanding and development of effective vaccines.
Collaborations
Abi-Ghanem has collaborated with notable colleagues, including Lisa Bielke and Sherryll Layton, who have also contributed to advancements in the field of immunology.
Conclusion
Daad Abi-Ghanem's innovative work in vaccine development highlights his commitment to enhancing public health through scientific research. His contributions are vital in the ongoing fight against infectious diseases.